BARDA VITAL Global Health Security Symposium

Thu Jun 27 2024 at 02:30 pm to 06:45 pm

Rahel Hirsch Center für Translationale Medizin (RHC) | Berlin

VITAL
Publisher/HostVITAL
BARDA VITAL  Global Health Security Symposium
Advertisement
Join us at the Rahel Hirsch Center in Berlin to discover solutions that enhance pandemic preparedness and response for a safer future.
About this Event

Join us for the BARDA VITAL Global Health Security Symposium at the Rahel Hirsch Center for Translational Medicine in Berlin — an exciting event focusing on visionary advancements in pandemic preparedness and response, vaccine and therapeutics innovation, and medical countermeasures aimed at enhancing pandemic preparedness and response for a safer future.


This dynamic symposium features invaluable networking opportunities, inspiring talks, and exciting company pitches. Connect with leading experts, researchers, and professionals from both sides of the Atlantic to explore the latest discoveries and strategies in preventing and addressing global health crises.


Agenda

  • 2:30 – 3:00 PM: Arrival & Registration
  • 3:00 – 3:45 PM: Welcome Remarks
  • 3:00 – 3:45 PM: Keynotes
  • 4:45 – 5:30 PM: Panel Discussion "Investing in Medical Countermeasures Globally"
  • 5:30 – 5:45 PM: Coffee Break
  • 5:45 – 6:45 PM: Pitch Event
  • 6:45PM: Networking


Keynote Speakers

  • Jano Costard, PhD, Head of Challenges, SPRIND – "Enabling Countermeasures for Future Pandemics Today"
  • Oliver Morgan, PhD, Director of Pandemic and Epidemic Intelligence Systems at the WHO Hub for Pandemic & Epidemic Intelligence
  • Hocine William Mankouri, PhD, Senior Scientific Lead Infectious Diseases, Novo Nordisk Foundation – "Introducing the New Novo Nordisk Foundation Initiative for Vaccines & Immunity (NIVI)"
  • Prof. Leif Erik Sander, MD, PhD, Chair, Department of Infectious Diseases & Respiratory Medicine, Charité - Universitätsmedizin Berlin


Panel Discussion "Investing in Medical Countermeasures Globally"

  • Christina Hertel Reinke, PhD, Head of Asset Management at EIT Health
  • Holger Reithinger, PhD, General Partner at Forbion
  • Ashim Subedee, PhD, Director, Catalyst Office at BARDA DRIVe
  • Annika Pierson, CEO, Americas at Start2 Group (Moderator)
<h4>
</h4>

Other Highlights

  • Exclusive Insights: Gain unique insights from esteemed speakers representing BARDA, VITAL, Charité, and the Berlin Institute of Health (BIH), and learn about their contributions to the healthcare landscape.
  • Startup Pitches and Awards*: Witness innovative innovations in critical areas such as rapid development platforms, broad-spectrum antimicrobial interventions, effective vaccines and therapeutics, host-directed treatments, and technology enhancements.
  • Food, Drinks, and Networking: Indulge in delicious refreshments and continue conversations with healthcare experts.
<h4>
</h4>

Join us for this engaging and insightful event that brings together key stakeholders in healthcare and innovation. Whether you're a startup, academic institution, or industry expert, this symposium invites you to explore cutting-edge solutions and connect with members of the U.S. and EU therapeutics and vaccine innovation community.

<h4>
</h4>

Don't miss out on shaping the future of healthcare innovation to prevent and treat global health crises — register now!



Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.

The BAN, comprised of 5 hubs, will serve as a global network supporting early-stage companies from around the world developing next-generation medical countermeasures (MCMs). The Hubs are focused on Diagnostics/Medical Devices, Therapeutics/Vaccines, Digital Health Tools, Special Populations, and Enabling Technologies.


VITAL, a BARDA Accelerator Network (BAN) Hub, supports the development and acceleration of next-generation therapeutic and vaccine platforms and technologies. It is led by Start2 Group in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs (BioLabs). VITAL provides a global innovation network to enable impactful collaborations between the U.S. and other health security communities and their innovation ecosystems around the world.

Advertisement

Event Venue & Nearby Stays

Rahel Hirsch Center für Translationale Medizin (RHC), Luisenstraße, Berlin, Germany

Tickets

EUR 0.00

Sharing is Caring: